| Reconciliation of revenue from segments to consolidated |
The following table reflects results of operations of the Company’s reportable segments (in millions): | | | | | | | | | | | | | | | | | | | 2024 | | 2023 | | 2022 | | Sales: | | | | | | | U.S. Retail Pharmacy | | | | | | | Pharmacy | $ | 88,867 | | | $ | 82,118 | | | $ | 80,434 | | | Retail | 26,911 | | | 28,195 | | | 28,643 | | | Total | $ | 115,778 | | | $ | 110,314 | | | $ | 109,078 | | | | | | | | | International | | | | | | | Pharmacy | $ | 3,598 | | | $ | 3,664 | | | $ | 3,727 | | | Retail | 7,887 | | | 7,324 | | | 6,924 | | | Wholesale | 12,067 | | | 11,211 | | | 11,178 | | | Total | $ | 23,552 | | | $ | 22,198 | | | $ | 21,830 | | | | | | | | | U.S. Healthcare | $ | 8,345 | | | $ | 6,570 | | | $ | 1,795 | | | | | | | | Corporate and Other 1 | $ | (16) | | | $ | — | | | $ | — | | | | | | | | | Walgreens Boots Alliance, Inc. | $ | 147,658 | | | $ | 139,081 | | | $ | 132,703 | | | | | | | | | Adjusted operating income: | | | | | | | U.S. Retail Pharmacy | $ | 2,167 | | | $ | 3,689 | | | $ | 5,029 | | | International | 793 | | | 935 | | | 726 | | | U.S. Healthcare | (134) | | | (566) | | | (370) | | Corporate and Other | (202) | | | (187) | | | (251) | | | Walgreens Boots Alliance, Inc. | $ | 2,624 | | | $ | 3,871 | | | $ | 5,133 | | | | | | | | | Depreciation and amortization: | | | | | | | U.S. Retail Pharmacy | $ | 1,422 | | | $ | 1,362 | | | $ | 1,415 | | | International | 370 | | | 328 | | | 355 | | | U.S. Healthcare | 651 | | | 560 | | | 211 | | | Corporate and Other | 16 | | | 8 | | | 9 | | | Walgreens Boots Alliance, Inc. | $ | 2,459 | | | $ | 2,257 | | | $ | 1,990 | | | | | | | | | Capital expenditures: | | | | | | | U.S. Retail Pharmacy | $ | 1,041 | | | $ | 1,421 | | | $ | 1,207 | | | International | 247 | | | 308 | | | 295 | | | U.S. Healthcare | 91 | | | 375 | | | 218 | | | Corporate and Other | 2 | | | 13 | | | 15 | | | Walgreens Boots Alliance, Inc. | $ | 1,381 | | | $ | 2,117 | | | $ | 1,734 | |
1.Includes certain eliminations.
|
| Reconciliation of operating profit (loss) from segments to consolidated |
The following table reconciles adjusted operating income to operating (loss) income (in millions): | | | | | | | | | | | | | | | | | | | | | | | 2024 | | 2023 | | 2022 | | Adjusted operating income (Non-GAAP measure): | | $ | 2,624 | | | $ | 3,871 | | | $ | 5,133 | | | Impairment of goodwill, intangibles and long-lived assets | | (13,422) | | | (299) | | | (783) | | | Acquisition-related amortization | | (1,075) | | | (1,126) | | | (855) | | | Transformational cost management | | (891) | | | (1,181) | | | (763) | | | Acquisition-related costs | | (542) | | | (323) | | | (223) | | | Certain legal and regulatory accruals and settlements | | (561) | | | (7,466) | | | (768) | | | Adjustments to equity earnings in Cencora | | (162) | | | (211) | | | (218) | | | LIFO provision | | (47) | | | (187) | | | (135) | | | | | | | | | | Store damage and inventory loss insurance recovery | | — | | | 40 | | | — | | | Operating (loss) income (GAAP measure) | | $ | (14,076) | | | $ | (6,882) | | | $ | 1,387 | |
|
| Geographic data for net sales |
Geographic data for sales is as follows (in millions): | | | | | | | | | | | | | | | | | | | | 2024 | | 2023 | | 2022 | | United States | $ | 124,176 | | | $ | 116,883 | | | $ | 110,873 | | | Germany | 12,067 | | | 11,211 | | | 11,178 | | | United Kingdom | 9,550 | | | 8,984 | | | 8,894 | | | Other | 1,864 | | | 2,003 | | | 1,757 | | | Sales | $ | 147,658 | | | $ | 139,081 | | | $ | 132,703 | |
|
| Geographic data for long-lived assets |
Geographic data for long-lived assets, defined as operating lease right-of-use assets and property, plant and equipment, is as follows (in millions): | | | | | | | | | | | | | | 2024 | | 2023 | | United States | $ | 25,873 | | | $ | 28,951 | | | United Kingdom | 3,538 | | | 3,622 | | | Other | 697 | | | 681 | | | Total long-lived assets | $ | 30,108 | | | $ | 33,254 | |
|